Meghmani Organics Limited has informed the Exchange regarding a press release dated May 14, 2026, titled "Press Release on Financial Results for Q4 FY 2026".
MOL · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
On the reaction day the stock moved 0.2 pts more than Nifty Microcap 250 and 0.7 pts more than its Pesticides & Agrochemicals peers, over the same two closes: a difference in percentage points, not a measure of what the filing did.
Minute windows have no benchmark: there is no intraday index history to compare against.
Meghmani Organics reported mixed Q4 FY26 results with standalone revenue of ₹456.6 crore, down 9% YoY due to subdued export demand from macroeconomic uncertainties and US tariffs. EBITDA fell sharply to ₹26.2 crore from ₹64.6 crore (down 59%) with margin compressing to 5.7% from 12.9% as input costs rose while realisations stayed stable. However, FY26 full-year performance was strong with revenue up 4% to ₹2,091.8 crore, EBITDA up 27% to ₹228.7 crore, and net profit surging 89% to ₹125.3 crore. The Crop Protection segment (78% of revenue) reported EBITDA margin of 14.9%, while the Pigments segment (22% of revenue) struggled with only 3.3% EBITDA margin and 40% capacity utilisation. TiO2 operations have been suspended due to commercial unviability from elevated raw material costs.
Q4 was weak due to export headwinds, but full-year FY26 was strong with near-doubling of net profit and margin expansion, suggesting resilience despite near-term macro pressures. TiO2 suspension and low pigment utilisation are concerns that could weigh on near-term sentiment.